Real-time enrollment status for this multiple sclerosis (ms) primary progressive clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:01 PM UTC
| NCT Number | NCT07067463 |
| Recruiting Status | Recruiting |
| Condition | Multiple Sclerosis (MS) Primary Progressive |
| Phase | PHASE3 |
| Target Enrollment | 705 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Zenas BioPharma (USA), LLC |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07067463 is currently recruiting participants. This phase3 study for multiple sclerosis (ms) primary progressive is actively seeking new participants at 18 locations across the United States. The study is sponsored by Zenas BioPharma (USA), LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07067463 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07067463 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.